139 related articles for article (PubMed ID: 34774868)
1. Toxicity and Cosmetic Outcome of Breast Irradiation in Women with Breast Cancer and Autoimmune Connective Tissue Disease: The Role of Fraction and Field Size.
Purswani JM; Jaros B; Oh C; Sandigursky S; Xiao J; Gerber NK
Pract Radiat Oncol; 2022; 12(2):e90-e100. PubMed ID: 34774868
[TBL] [Abstract][Full Text] [Related]
2. Breast Conservation in Women with Autoimmune Disease: The Role of Active Autoimmune Disease and Hypofractionation on Acute and Late Toxicity in a Case-Controlled Series.
Purswani JM; Oh C; Jaros B; Sandigursky S; Xiao J; Gerber NK
Int J Radiat Oncol Biol Phys; 2021 Jul; 110(3):783-791. PubMed ID: 33545303
[TBL] [Abstract][Full Text] [Related]
3. Acute and Short-term Toxic Effects of Conventionally Fractionated vs Hypofractionated Whole-Breast Irradiation: A Randomized Clinical Trial.
Shaitelman SF; Schlembach PJ; Arzu I; Ballo M; Bloom ES; Buchholz D; Chronowski GM; Dvorak T; Grade E; Hoffman KE; Kelly P; Ludwig M; Perkins GH; Reed V; Shah S; Stauder MC; Strom EA; Tereffe W; Woodward WA; Ensor J; Baumann D; Thompson AM; Amaya D; Davis T; Guerra W; Hamblin L; Hortobagyi G; Hunt KK; Buchholz TA; Smith BD
JAMA Oncol; 2015 Oct; 1(7):931-41. PubMed ID: 26247543
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.
Yoon SM; Chu FI; Ruan D; Steinberg ML; Raldow A; Lee P
JAMA Netw Open; 2021 Feb; 4(2):e2034074. PubMed ID: 33599771
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated radiation treatment in the management of breast cancer.
Gupta A; Ohri N; Haffty BG
Expert Rev Anticancer Ther; 2018 Aug; 18(8):793-803. PubMed ID: 29902386
[TBL] [Abstract][Full Text] [Related]
6. Hypofractionated whole breast irradiation after conservative surgery for patients aged less than 60 years: a multi-centre comparative study.
Meattini I; Poortmans P; Kirova Y; Saieva C; Visani L; Salvestrini V; Kim J; Jung W; Olmetto E; Mariotti M; Desideri I; Fourquet A; Livi L; Kim K
Acta Oncol; 2020 Feb; 59(2):188-195. PubMed ID: 31760849
[No Abstract] [Full Text] [Related]
7. A phase II randomized clinical trial to assess toxicity and quality of life of breast cancer patients with hypofractionated versus conventional fractionation radiotherapy with regional nodal irradiation in the context of COVID-19 crisis.
Gil GOB; de Andrade WP; Diniz PHC; Cantidio FS; Queiroz IN; Gil MLBV; Almeida CAM; Caldeira PPR; Regalin M; Silva-Filho AL
Front Oncol; 2023; 13():1202544. PubMed ID: 37388233
[TBL] [Abstract][Full Text] [Related]
8. Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F; De Santis MC; Meduri B; Franzese C; Franceschini D; Franco P; Pasinetti N; Lancellotta V; Giacobazzi P; La Rocca E; D'Angelo E; Lozza L; Livi L; Meattini I; Scorsetti M
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2069-2077. PubMed ID: 33387035
[TBL] [Abstract][Full Text] [Related]
9. Local control in young women with early-stage breast cancer treated with hypofractionated whole breast irradiation.
Rock K; Ng S; Murray L; Su J; Fyles A; Koch CA
Breast; 2018 Oct; 41():89-92. PubMed ID: 30015257
[TBL] [Abstract][Full Text] [Related]
10. Hypofractionated Adjuvant Radiation Therapy Is Effective for Patients With Lymph Node-Positive Breast Cancer: A Population-Based Analysis.
Koulis TA; Nichol AM; Truong PT; Speers C; Gondara L; Tyldesley S; Lohrisch C; Weir L; Olson RA
Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1150-1158. PubMed ID: 32721421
[TBL] [Abstract][Full Text] [Related]
11. Patient preference study comparing hypofractionated versus conventionally fractionated whole-breast irradiation after breast-conserving surgery.
Kawaguchi H; Tsujino K; Miki M; Matsumoto Y; Ota Y; Hirokaga K; Takao S; Soejima T; Sasaki R
Jpn J Clin Oncol; 2019 Jun; 49(6):545-553. PubMed ID: 30796835
[TBL] [Abstract][Full Text] [Related]
12. Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry.
Schmeel LC; Koch D; Schmeel FC; Röhner F; Schoroth F; Bücheler BM; Mahlmann B; Leitzen C; Schüller H; Tschirner S; Fuhrmann A; Heimann M; Brüser D; Abramian AV; Müdder T; Garbe S; Vornholt S; Schild HH; Baumert BG; Wilhelm-Buchstab TM
Radiother Oncol; 2020 May; 146():172-179. PubMed ID: 32171945
[TBL] [Abstract][Full Text] [Related]
13. Patient-reported Long-term Cosmetic Outcomes Following Short Fractionation Whole Breast Radiotherapy With Boost.
Chan EK; Tabarsi N; Tyldesley S; Khan M; Woods R; Speers C; Weir L
Am J Clin Oncol; 2016 Oct; 39(5):473-8. PubMed ID: 24824143
[TBL] [Abstract][Full Text] [Related]
14. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
[TBL] [Abstract][Full Text] [Related]
15. Hypofractionated Nodal Radiation Therapy for Breast Cancer Was Not Associated With Increased Patient-Reported Arm or Brachial Plexopathy Symptoms.
Leong N; Truong PT; Tankel K; Kwan W; Weir L; Olivotto IA
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1166-1172. PubMed ID: 29165285
[TBL] [Abstract][Full Text] [Related]
16. Five-Year Longitudinal Analysis of Patient-Reported Outcomes and Cosmesis in a Randomized Trial of Conventionally Fractionated Versus Hypofractionated Whole-Breast Irradiation.
Weng JK; Lei X; Schlembach P; Bloom ES; Shaitelman SF; Arzu IY; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):360-370. PubMed ID: 33992718
[TBL] [Abstract][Full Text] [Related]
17. Three-Year Outcomes With Hypofractionated Versus Conventionally Fractionated Whole-Breast Irradiation: Results of a Randomized, Noninferiority Clinical Trial.
Shaitelman SF; Lei X; Thompson A; Schlembach P; Bloom ES; Arzu IY; Buchholz D; Chronowski G; Dvorak T; Grade E; Hoffman K; Perkins G; Reed VK; Shah SJ; Stauder MC; Strom EA; Tereffe W; Woodward WA; Amaya DN; Shen Y; Hortobagyi GN; Hunt KK; Buchholz TA; Smith BD
J Clin Oncol; 2018 Oct; 36(35):JCO1800317. PubMed ID: 30379626
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the use of hypofractionated and conventionally fractionated radiotherapy in early breast cancer: A single-center real-world study in Taiwan.
Chuang WK; Cheng SH; Hung CF; Huang TT; Jen CW; Yen JH; Tsai YC
J Formos Med Assoc; 2022 Aug; 121(8):1588-1595. PubMed ID: 35094914
[TBL] [Abstract][Full Text] [Related]
19. Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial.
Ahlawat S; Haffty BG; Goyal S; Kearney T; Kirstein L; Chen C; Moore DF; Khan AJ
Int J Radiat Oncol Biol Phys; 2016 Jan; 94(1):118-125. PubMed ID: 26700706
[TBL] [Abstract][Full Text] [Related]
20. Acute Toxicity and Quality of Life of Hypofractionated Radiation Therapy for Breast Cancer.
Arsenault J; Parpia S; Goldberg M; Rakovitch E; Reiter H; Doherty M; Lukka H; Sussman J; Wright J; Julian J; Whelan T
Int J Radiat Oncol Biol Phys; 2020 Aug; 107(5):943-948. PubMed ID: 32334033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
